EBRO 2017

Cooper et al. (RTOG) NEJM, 2004

10%

High risk

Concomitant radiotherapy + chemotherapy

Intermediate + high risk

13%

Bernier et al. (EORTC) NEJM, 2004

Made with FlippingBook Learn more on our blog